Nocturnal nasal postive pressure ventilation plus oxygen therapy versus oxygen alone in severe stable chronic obstructive pulmonary disease

ISRCTN ISRCTN24818612
DOI https://doi.org/10.1186/ISRCTN24818612
Secondary identifying numbers 921019
Submission date
10/10/2002
Registration date
10/10/2002
Last edited
01/07/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr DSC Hui
Scientific

Department of Medicine & Therapeutics
Prince of Wales Hospital
Chinese University of Hong Kong
-
-
Hong Kong

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedRespiratory diseases
InterventionPatients will then be randomized into two groups receiving:
1. Non-invasive positive pressure ventilation (NPPV) plus LTOT, or
2. LTOT plus oral placebo over a 3-month period.

NPPV will be delivered via a portable bilevel positive airway pressure (BiPAP) Duet device via a nasal or oral-nasal mask.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)oxygen
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2002
Completion date31/12/2002

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteriaPatients with severe stable chronic obstructive pulmonary disease with hypercapnic respiratory failure already on domiciliary long-term oxygen therapy (LTOT)
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment01/01/2002
Date of final enrolment31/12/2002

Locations

Countries of recruitment

  • China
  • Hong Kong

Study participating centre

Department of Medicine & Therapeutics
-
-
Hong Kong

Sponsor information

Hong Kong Health Services Research Fund (Hong Kong)
Government

Health Welfare and Food Bureau
Government Secretariat, HKSAR
20th floor Murray Building
Garden Road
-
-
Hong Kong

Phone +852 (0)2973 8288
Email hsrf@hwfb.gov.hk
Website http://www.fhb.gov.hk/grants/english/funds/funds_hhsrf/funds_hhsrf_abt/funds_hhsrf_abt.html
ROR logo "ROR" https://ror.org/03qh32912

Funders

Funder type

Government

Hong Kong Health Services Research Fund (Hong Kong)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan